David A. Greenberg
#144,780
Most Influential Person Now
David A. Greenberg's AcademicInfluence.com Rankings
David A. Greenbergbiology Degrees
Biology
#10454
World Rank
#13785
Historical Rank
Neuroscience
#1618
World Rank
#1669
Historical Rank

Download Badge
Biology
Why Is David A. Greenberg Influential?
(Suggest an Edit or Addition)David A. Greenberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo (2002) (1459)
- VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. (2003) (1110)
- Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat (2001) (1081)
- Increased hippocampal neurogenesis in Alzheimer's disease (2003) (981)
- Drugs, neurotransmitters, and schizophrenia. (1974) (792)
- Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. (2000) (678)
- Evidence for stroke-induced neurogenesis in the human brain (2006) (589)
- Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum (2003) (531)
- Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. (1977) (530)
- From angiogenesis to neuropathology (2005) (502)
- Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures (1999) (467)
- Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. (2004) (459)
- Neurogenesis and aging: FGF‐2 and HB‐EGF restore neurogenesis in hippocampus and subventricular zone of aged mice (2003) (422)
- Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects. (1974) (405)
- Neuroglobin protects the brain from experimental stroke in vivo (2003) (347)
- Early Detection of DNA Strand Breaks in the Brain After Transient Focal Ischemia: Implications for the Role of DNA Damage in Apoptosis and Neuronal Cell Death (1997) (319)
- Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. (1978) (301)
- Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. (1976) (280)
- Stem cell factor stimulates neurogenesis in vitro and in vivo. (2002) (279)
- Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury (2001) (269)
- Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain (1977) (267)
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis (2009) (266)
- Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. (2004) (261)
- Muscarinic cholinergic receptor binding: regional distribution in monkey brain (1974) (235)
- Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility (2003) (232)
- Correction for Galvan et al., Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 (2006) (224)
- Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice (2002) (218)
- Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia (2006) (205)
- Vascular endothelial growth factors (VEGFs) and stroke (2013) (204)
- Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice (2010) (203)
- FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. (2005) (199)
- Ethanol regulates calcium channels in clonal neural cells. (1986) (191)
- Heparin-Binding Epidermal Growth Factor-Like Growth Factor: Hypoxia-Inducible Expression In Vitro and Stimulation of Neurogenesis In Vitro and In Vivo (2002) (190)
- VEGF‐overexpressing transgenic mice show enhanced post‐ischemic neurogenesis and neuromigration (2007) (184)
- Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats (2000) (183)
- Microarray analysis of hippocampal gene expression in global cerebral ischemia (2001) (182)
- Transplantation of Human Neural Precursor Cells in Matrigel Scaffolding Improves Outcome from Focal Cerebral Ischemia after Delayed Postischemic Treatment in Rats (2010) (182)
- Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. (2006) (178)
- Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat (2005) (178)
- MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad (2002) (174)
- Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression (2003) (170)
- Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice (2007) (167)
- Induction of vascular endothelial growth factor and hypoxia-inducible factor-1α by global ischemia in rat brain (2000) (159)
- Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor (2001) (157)
- Neuroglobin: an endogenous neuroprotectant. (2008) (146)
- Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. (2006) (142)
- Age-related Impairment of Vascular Structure and Functions (2017) (141)
- mTOR Signaling Inhibition Modulates Macrophage/Microglia-Mediated Neuroinflammation and Secondary Injury via Regulatory T Cells after Focal Ischemia (2014) (137)
- Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity (2000) (126)
- Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. (1983) (125)
- Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo (2007) (124)
- Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat (1998) (121)
- Involvement of Notch1 Signaling in Neurogenesis in the Subventricular Zone of Normal and Ischemic Rat Brain in Vivo (2009) (121)
- Dextromethorphan and dextrorphan as calcium channel antagonists (1988) (119)
- Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures (1996) (116)
- Ischemia‐induced neurogenesis is preserved but reduced in the aged rodent brain (2004) (113)
- Alzheimer's disease drugs promote neurogenesis (2006) (112)
- CB1 cannabinoid receptor induction in experimental stroke (2000) (108)
- Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity (2006) (101)
- Hemin induces neuroglobin expression in neural cells. (2002) (101)
- Cerebral neurogenesis is induced by intranasal administration of growth factors (2003) (100)
- Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression (2003) (99)
- Post-ischemic Administration of Heparin-Binding Epidermal Growth Factor-like Growth Factor (HB-EGF) Reduces Infarct Size and Modifies Neurogenesis after Focal Cerebral Ischemia in the Rat (2004) (98)
- p38 Mitogen-activated Protein Kinase Mediates Hypoxic Regulation of Mdm2 and p53 in Neurons* (2002) (92)
- Notch-1 signalling is activated in brain arteriovenous malformations in humans. (2009) (92)
- Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis (2004) (90)
- Effect of human neural precursor cell transplantation on endogenous neurogenesis after focal cerebral ischemia in the rat (2011) (90)
- Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats (2012) (89)
- Regulation of hypoxic neuronal death signaling by neuroglobin (2008) (87)
- Epileptic tolerance: prior seizures protect against seizure-induced neuronal injury (1995) (86)
- Increased Severity of Cerebral Ischemic Injury in Vascular Endothelial Growth Factor-B–Deficient Mice (2004) (86)
- Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice (2012) (86)
- Neuroglobin Expression in Ischemic Stroke (2010) (84)
- Neuroglobin protects against nitric oxide toxicity (2008) (83)
- Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease. (2013) (83)
- Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal (2000) (82)
- Neuronal Nitric Oxide Synthase and Ischemia-Induced Neurogenesis (2005) (82)
- Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line. (1987) (81)
- Hypoxic Induction of Endoglin via Mitogen-Activated Protein Kinases in Mouse Brain Microvascular Endothelial Cells (2003) (79)
- α-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists (1978) (78)
- Reelin-deficient mice show impaired neurogenesis and increased stroke size (2006) (78)
- Endothelins and the nervous system (1992) (76)
- Enhancement of NMDA toxicity and calcium responses by chronic exposure of cultured cortical neurons to ethanol (1994) (73)
- Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat (2006) (73)
- Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease (2008) (73)
- Ethanol and the γ‐Aminobutyric Acid‐Benzodiazepine Receptor Complex (1984) (73)
- cDNA Microarray Analysis of Changes in Gene Expression Induced by Neuronal Hypoxia in Vitro (2004) (71)
- Fas (CD95) May Mediate Delayed Cell Death in Hippocampal CA1 Sector after Global Cerebral Ischemia (2001) (71)
- Neurogenesis after Primary Intracerebral Hemorrhage in Adult Human Brain (2008) (70)
- Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3′-kinase/Akt signaling by global cerebral ischemia in the rat (2000) (70)
- Interaction of calmodulin inhibitors and protein kinase C inhibitors with voltage-dependent calcium channels (1987) (68)
- Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. (1985) (67)
- Ethanol-induced component of 45Ca2+ uptake in PC12 cells is sensitive to Ca2+ channel modulating drugs (1987) (66)
- Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures (1998) (63)
- Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes. (1978) (61)
- Effect of aging on neuroglobin expression in rodent brain (2005) (58)
- Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury (2005) (58)
- Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis (2006) (58)
- Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats (2010) (57)
- Calcium channel antagonists and the treatment of migraine. (1986) (55)
- Hypoxia-inducible factor-1 and neuroglobin expression (2012) (55)
- Ethanol inhibits excitotoxicity in cerebral cortical cultures (1992) (53)
- Antischizophrenic drugs: Affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects (1974) (53)
- Effect of Suture Properties on Stability of Middle Cerebral Artery Occlusion Evaluated by Synchrotron Radiation Angiography (2012) (53)
- Presence of neuroglobin in cultured astrocytes (2005) (52)
- Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia (2007) (50)
- Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function. (1978) (49)
- Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases (2017) (48)
- Selective labeling of α-noradrenergic receptors in rat brain with [3H] dihydroergokryptine (1977) (44)
- Inhibition of calcium flux and calcium channel antagonist binding in the PC12 neural cell line by phorbol esters and protein kinase C. (1986) (44)
- Ethanol and Excitotoxicity in Cultured Cortical Neurons: Differential Sensitivity of N‐Methyl‐D‐Aspartate and Sodium Nitroprusside Toxicity (1992) (43)
- Antagonist drug selectivity for radioligand binding sites on voltage-gated and N-methyl-d-aspartate receptor-gated Ca2+ channels (1989) (43)
- Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease (2013) (40)
- Interactive effect of cytochrome P450 17α-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia (2002) (40)
- Neurodegeneration and neurogenesis: focus on Alzheimer's disease. (2006) (37)
- Pharmacological Induction of Neuroglobin Expression (2011) (37)
- Heparin‐binding epidermal growth factor‐like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3′‐kinase and mitogen‐activated protein kinase (2005) (37)
- Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia (2003) (36)
- Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells. (1986) (35)
- Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures (1992) (35)
- VEGF and ALS: the luckiest growth factor? (2004) (35)
- Periodic EEG complexes in infectious mononucleosis encephalitis. (1982) (34)
- SK&F 96365, a receptor-mediated calcium entry inhibitor, inhibits calcium responses to endothelin-1 in NG108-15 cells. (1991) (34)
- Calcium channel ‘agonist’ BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes (1984) (33)
- Growth factors and stroke (2006) (33)
- Regional distribution of α-noradrenergic receptor binding in calf brain (1977) (33)
- Endothelin and calcium signaling in NG108-15 neuroblastoma x glioma cells. (1991) (33)
- Stimulation of Calcium Uptake in PC12 Cells by the Dihydropyridine Agonist BAY K 8644 (1985) (32)
- Neuroglobin protein is upregulated in Alzheimer's disease. (2013) (32)
- Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects. (1974) (31)
- Expression of poly(C)-binding proteins is differentially regulated by hypoxia and ischemia in cortical neurons (2002) (30)
- Comparative Effects of Chronic Exposure to Ethanol and Calcium Channel Antagonists on Calcium Channel Antagonist Receptors in Cultured Neural (PC12) Cells (1989) (29)
- MicroRNA‐137 and microRNA‐195* inhibit vasculogenesis in brain arteriovenous malformations (2017) (28)
- DNA microarray analysis of cannabinoid signaling in mouse brain in vivo. (2002) (28)
- A neuroglobin-overexpressing transgenic mouse. (2007) (28)
- Expression of the RNA‐binding protein TIAR is increased in neurons after ischemic cerebral injury (2000) (27)
- Neurogenesis associated with endothelin-induced cortical infarction in the mouse (2007) (27)
- Tales of transdifferentiation (2003) (26)
- Comparative neurotoxic potential of glutamate, endothelins, and plateletactivating factor in cerebral cortical cultures (1992) (26)
- The jaundice of the cell (2002) (25)
- Pre- and post-synaptic modulators of excitatory neurotransmission: comparative effects on hypoxia/hypoglycemia in cortical cultures (1994) (25)
- Altered Expression of the Neuropeptide-Processing Enzyme Carboxypeptidase E in the Rat Brain after Global Ischemia (2001) (24)
- Bax κ, a novel Bax splice variant from ischemic rat brain lacking an ART domain, promotes neuronal cell death (2001) (24)
- Antiparkinsonian drugs and in vitro excitotoxicity (1992) (24)
- Vascular endothelial growth factor-B expression in postischemic rat brain (2013) (24)
- Two caspase‐2 transcripts are expressed in rat hippocampus after global cerebral ischemia (2002) (23)
- Angiogenesis and stroke. (1998) (23)
- Electrophysiological neurodifferentiation of subventricular zone-derived precursor cells following stroke (2008) (22)
- Proteomic Analysis of Neuronal Hypoxia In vitro (2004) (22)
- Interactions between vascular endothelial growth factor and neuroglobin (2012) (22)
- Neurogenesis and stroke. (2007) (22)
- Striatal calcium channel antagonist receptors in huntington's disease and parkinson's disease (1988) (22)
- Increased expression of apoptosis-linked gene 2 (ALG2) in the rat brain after temporary focal cerebral ischemia (2000) (22)
- Neuroglobin expression in neurogenesis (2013) (20)
- Mining DNA microarray data using a novel approach based on graph theory (2001) (19)
- Neuroglobin Overexpression Inhibits AMPK Signaling and Promotes Cell Anabolism (2016) (19)
- A novel inhibitor of glutamate release reduces excitotoxic injury in vitro (1992) (19)
- Calcium channel antagonist receptors in cerebral cortex from alcoholic patients (1989) (19)
- Cerebral angiogenesis: a realistic therapy for ischemic disease? (2014) (18)
- The role of vascular endothelial growth factor in neurogenesis in adult brain. (2006) (17)
- Turning neurogenesis up a Notch (2006) (17)
- Neuromuscular disease and calcium channels (1999) (16)
- Inactivation of 45Ca2+ uptake by prior depolarization of PC12 cells (1985) (15)
- Lectin‐Induced Enhancement of Voltage‐Dependent Calcium Flux and Calcium Channel Antagonist Binding (1987) (15)
- Cation interactions with putative NMDA receptor-gated channels labeled by [3H]MK-801 in rat cerebral cortex (1988) (14)
- Neuroglobin expression in human arteriovenous malformation and intracerebral hemorrhage. (2011) (14)
- Endothelium-induced proliferation and electrophysiological differentiation of human embryonic stem cell-derived neuronal precursors. (2008) (14)
- Effect of a contralateral lesion on neurological recovery from stroke in rats. (2012) (14)
- Regenerating the brain. (2007) (14)
- Effect of ethanol on [3H]nitrendipine binding to calcium channels in brain membranes. (1984) (13)
- Bax kappa, a novel Bax splice variant from ischemic rat brain lacking an ART domain, promotes neuronal cell death. (2001) (12)
- Neuronal injury in experimental status epilepticus in the rat: role of hypoxia (1997) (12)
- Ero1‐L, an ischemia‐inducible gene from rat brain with homology to global ischemia‐induced gene 11 (Giig11), is localized to neuronal dendrites by a dispersed identifier (ID) element‐dependent mechanism (2003) (11)
- Poststroke angiogenesis, pro: making the desert bloom. (2015) (11)
- Comparative protein interactomics of neuroglobin and myoglobin (2012) (10)
- Linking acquired neurodevelopmental disorders to defects in cell adhesion (2003) (10)
- Intracellular calcium in NCB-20 cells: elevation by depolarization and ethanol but not by glutamate (1991) (9)
- Effects of glucose on calcium channels in neural cells (1991) (9)
- Experiencing VEGF (2004) (9)
- Electrophysiological properties of subventricular zone cells in adult mouse brain (2010) (9)
- Wernicke-Korsakoff syndrome. (1984) (9)
- Corpus Callosum and Experimental Stroke: Studies in Callosotomized Rats and Acallosal Mice (2011) (8)
- LOX-1 expression and oxidized LDL uptake and toxicity in the HN33 neuronal cell line (2014) (7)
- Electrophysiological properties of mouse cortical neuron progenitors differentiated in vitro and in vivo. (2008) (7)
- Microarrays, markers of disease, and the myth of “nonhypothesis‐driven” research (2001) (6)
- Regional distribution of alpha-noradrenergic receptor binding in calf brain. (1977) (6)
- Ethanol and the gamma-aminobutyric acid-benzodiazepine receptor complex. (1984) (6)
- Preclinical stroke research: gains and gaps. (2013) (5)
- A Bcl‐2 antisense oligonucleotide increases α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) toxicity in cortical cultures (1997) (5)
- ω-Agatoxin IVA and excitotoxicity in cortical neuronal cultures (1996) (5)
- Flow-induced regulation of brain endothelial cells in vitro. (2014) (5)
- Effects of flow on LOX-1 and oxidized low-density lipoprotein interactions in brain endothelial cell cultures. (2015) (4)
- Ethanol and sedatives. (1993) (4)
- Calcium indicators and excitotoxicity in cultured cortical neurons (1993) (4)
- Another weapon against amyloid. (2006) (4)
- Reversible Dihydropyridine Isothiocyanate Binding to Brain Calcium Channels (1985) (3)
- Calcium entry activators: Distinct sites of dihydropyridine and aminopyridine action (1984) (3)
- Stem Cells and Stroke Recovery: Introduction (2007) (2)
- Neural gene therapy: Sensational finding (2005) (2)
- Stroke. Pathophysiology, diagnosis, and mangement, ed 2. Edited by Henry J. M. Bamett, Bennett M. Stein, J. P. Mohr, and Frank M. Yatsu, New York, Churchill Livingstone, 1992, 1,270 pp, illustrated, $225.00 (1993) (1)
- via Regulatory T Cells after Focal Ischemia Neuroinflammation and Secondary Injury Macrophage/Microglia-Mediated mTOR Signaling Inhibition Modulates (2014) (1)
- Basic neurochemistry: Molecular, cellular and medical aspects, ed 5. Edited by George, J. Siegel, Bernard W. Agranoff, R. Wayne Albers, and Perry B. Molinoff New York, Raven Press, 1994, 1080 pp, illustrated, $84.00 (1994) (1)
- A&D, a bridge between aging and age-related disease. (2010) (1)
- Molecular basis of neurology. Edited by P. Michael Conneally, Pad Boston, Blackwell Scientific, 1992 296 pp, illustrated, $39.95 (1993) (0)
- Book Review Diseases of the Nervous System: Clinical neurobiology Second edition. Edited by Arthur K. Asbury, Guy M. McKhann, and W. Ian McDonald. 1619 pp. in two volumes, illustrated. Philadelphia, W.B. Saunders, 1992. $250. ISBN 0–7216–3208–4 . (1992) (0)
- Channelopathies of the Nervous System edited by M. Rose and R.C. Griggs, 347 pp., ill., Oxford, Butterworth Heinemann, 2001, $95.00 (2002) (0)
- Erratum: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, (7130-7135)) (2007) (0)
- Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine. (1977) (0)
- Current therapy in neurologic disease, ed 4. Edited by Richard T. Johnson and John W. Griffin St Louis. B. C. Decker/Mosby–Year Book. 1993, 427 pp. illustrated (1994) (0)
- Alcohol, Neurodegenerative Disorders, and Calcium Channel Antagonist Receptors (1988) (0)
- The Neuron, by I.B. Levitan and L.K. Kaczmarek, 603 pp., ill., New York, Oxford University Press, 2002, $59.95 (2002) (0)
- The headaches. Edited by Jes Olesen, Peer Tfelt‐Hansen, and K. M. A. Welch, New York, Raven, 1993, 894 pp, illustrated, $165.00 (1994) (0)
- Cell death and diseases of the nervous system (1999) (0)
- Mice Corpus Callosum and Experimental Stroke : Studies in Callosotomized Rats and Acallosal (2011) (0)
- [abstract] REPARATIVE OSTEOGENESIS AND NEOVASCULARIZATION IN A BONE CHAMBER: EFFECT OF HBO. (1989) (0)
- Microarrays for the neurosciences: An essential guide (2002) (0)
- Neuroglobin Overexpression Inhibits AMPK Signaling and Promotes Cell Anabolism (2015) (0)
- Book Review Stroke: A Clinical Approach Second edition. By Louis R. Caplan. 562 pp., illustrated. Boston, Butterworth-Heinemann, 1993. $90. 0-7506-9181-6 (1993) (0)
- P9 - NEUROGLOBIN AS A NEUROPROTECTANT (2013) (0)
- Neurogenesis in Cerebrovascular Disease (2017) (0)
- Corrections. (2022) (0)
- O4-05-03 A key role of the C-terminal cleavage of APP in Alzheimer’s disease (2006) (0)
- Neurogenesis in Diseases of Aging (2009) (0)
- Vascular endothelial growth factors (VEGFs) and stroke (2013) (0)
- Cannabinoids and neuroprotection in stroke (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David A. Greenberg?
David A. Greenberg is affiliated with the following schools: